USANA Health Sciences (USNA) Tops Q4 EPS by 15c, provides guidance
Tweet
Share
E-mailGet Alerts USNA Hot Sheet
Price: $15.20 +1.60%
Revenue Growth %: +5.0%
Financial Fact:
Selling, general and administrative: 60.59M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Revenue Growth %: +5.0%
Financial Fact:
Selling, general and administrative: 60.59M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
USANA Health Sciences (NYSE: USNA) reported Q4 EPS of $0.64, $0.15 better than the analyst estimate of $0.49. Revenue for the quarter came in at $214 million versus the consensus estimate of $208.84 million.
GUIDANCE:
USANA Health Sciences sees FY2025 EPS of $2.35-$3.00, versus the consensus of $2.87. USANA Health Sciences sees FY2025 revenue of $920-1000 million, versus the consensus of $934.5 million.
For earnings history and earnings-related data on USANA Health Sciences (USNA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Casey's General Stores (CASY) Tops Q1 EPS by 69c
- United Natural Foods (UNFI) Tops Q4 EPS by 8c ; Offers Guidance
- BMO Capital Starts Carter's (CRI) at Outperform
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
